The Czechoslovak Group has spent the first half of 2026 winning contracts, hiring talent from NATO’s top defence contractors, and expanding into North America — yet its share price remains pinned near record lows. The disconnect between operational momentum and market sentiment is nowhere starker than at its truck-making subsidiary Tatra Trucks, where a botched capital increase has opened a new front in an already crowded governance battle.
CSG shares ended Friday at €13.67, a marginal gain of 1.17% on the day but still nursing a weekly loss of 6.32% and a monthly decline of 4.71%. The stock has shed roughly 62% since its 52-week high of €36.05, touched just three days after its landmark January 23 IPO on Euronext Amsterdam — the largest defence listing in history. At €13.60 billion, the group’s market capitalisation sits barely 12% above the 52-week trough of €12.20 reached in late June.
Tatra’s Borrowing Squeeze
The immediate pressure point is at Tatra Trucks, where an extraordinary general meeting failed to secure the 80% shareholder approval needed for a CZK 2.2 billion capital increase. Instead, the meeting authorised a large loan from Ytara SPV, a private company controlled by CSG owner Michal Strnad. The move effectively makes Strnad Tatra’s sole meaningful creditor.
Minority shareholder Promet Tools, which owns 35% of Tatra via its subsidiary, voted against the measure and is threatening legal action. The company argues the loan structure hands Strnad the ability to tighten his grip on Tatra over time, bypassing traditional governance safeguards. CSG backs Tatra’s management in a separate but related dispute: a planned acquisition by STV Invest of a 50% stake in Promet Tools — which in turn holds that 35% Tatra position — has prompted Tatra to appeal directly to the European Commission for a full competition review, fearing a rival could gain access to sensitive know-how.
Growth Story Intact, But Trust Is Thin
Operationally, the Prague-based munitions and vehicle group is making headway. A subsidiary has completed the technology transfer of propellant powder to Poland’s MESKO, feeding modular charges for 155 mm artillery rounds — a critical piece of NATO efforts to localise supply chains on the eastern flank.
Should investors sell immediately? Or is it worth buying CSG?
In North America, the newly formed CSG Land Systems North America, headquartered in Michigan, bundles Excalibur Army, Tatra Defence, and Tatra Trucks under one roof. The subsidiary will pursue US contracts for howitzers and all-terrain military vehicles, and has recruited executives from Rheinmetall, Northrop Grumman, Raytheon, BAE Systems, General Dynamics, and Kongsberg. It builds on an existing foothold: in 2025, CSG’s MSM Group North America won a contract to modernise 155 mm projectile production at the Iowa Army Ammunition Plant, with a target of 36,000 shells per month.
Despite these advances, the stock cannot shake the shadow of a critical report published earlier this year by short-seller Hunterbrook. The report alleged that CSG omitted information from its IPO prospectus and undervalued certain ownership stakes. CSG has dismissed the claims as unfounded, describing the pre-IPO restructuring as standard practice involving non-core businesses. Yet the company’s own governance structure — where CSG FIN controls the group and is itself indirectly controlled by Strnad through Ytara — continues to fuel investor caution.
Another Political Bet: KNDS Stake
The group has also floated a proposal to take a stake in the Franco-German tank maker KNDS. Any such deal would face close political scrutiny in Paris and Berlin, adding another layer of uncertainty to a stock that already trades with an annualised 30-day volatility of 51.7%. The relative strength index of 42.4 points to neutral conditions, neither oversold nor showing upward momentum.
What’s Next
The immediate catalysts are clear. Technically, the 50-day moving average at €15.46 is the first real barrier to any recovery, while the 52-week low at €12.20 serves as a psychological floor. In the corporate arena, the Tatra legal dispute could escalate or be resolved, and fresh details on the KNDS approach may shift sentiment quickly given the political dimension.
Above all, the market is waiting for the half-year report. Management is expected to reaffirm its full-year guidance and address lingering questions about capital allocation. Until that report — or a decisive resolution of the governance battles — the stock looks likely to remain caught between an expanding order book and a deficit of trust.
Ad
CSG Stock: Buy or Sell?! New CSG Analysis from July 12 delivers the answer:
The latest CSG figures speak for themselves: Urgent action needed for CSG investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 12.
CSG: Buy or sell? Read more here...
